ly 274614 has been researched along with u-50488 in 3 studies
Studies (ly 274614) | Trials (ly 274614) | Recent Studies (post-2010) (ly 274614) | Studies (u-50488) | Trials (u-50488) | Recent Studies (post-2010) (u-50488) |
---|---|---|---|---|---|
96 | 0 | 15 | 1,664 | 3 | 209 |
Protein | Taxonomy | ly 274614 (IC50) | u-50488 (IC50) |
---|---|---|---|
Delta-type opioid receptor | Rattus norvegicus (Norway rat) | 2.15 | |
Kappa-type opioid receptor | Mus musculus (house mouse) | 0.0027 | |
Mu-type opioid receptor | Rattus norvegicus (Norway rat) | 2.15 | |
Kappa-type opioid receptor | Rattus norvegicus (Norway rat) | 0.7171 | |
Kappa-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0958 | |
Kappa-type opioid receptor | Homo sapiens (human) | 0.0537 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Elliott, K; Inturrisi, CE; Kolesnikov, YA; Minami, N; Pasternak, GW | 1 |
Elliott, K; Inturrisi, CE; Kao, B; Kest, B; Man, A | 1 |
Bhargava, HN; Thorat, SN | 1 |
1 review(s) available for ly 274614 and u-50488
Article | Year |
---|---|
N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Dextromethorphan; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Isoquinolines; Narcotics; Nitric Oxide Synthase; Opioid-Related Disorders; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1995 |
2 other study(ies) available for ly 274614 and u-50488
Article | Year |
---|---|
The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginine, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Amino Acid Oxidoreductases; Analgesics; Animals; Arginine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Drug Tolerance; Injections, Subcutaneous; Isoquinolines; Male; Mice; Morphine; Naloxone; Nitric Oxide Synthase; Nitroarginine; Pyrrolidines; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1994 |
Differential effects of LY235959, a competitive antagonist of the NMDA receptor on kappa-opioid receptor agonist induced responses in mice and rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Binding, Competitive; Excitatory Amino Acid Antagonists; Isoquinolines; Male; Mice; Pain Measurement; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, kappa | 1997 |